AR-based neuronavigation trial opens recruiting as surgery tools get more precise — LiveFuture News
Open on LiveFuture.ai →

AR-based neuronavigation trial opens recruiting as surgery tools get more precise

A ClinicalTrials.gov registry observation shows a recruiting study of AR-based neuronavigation at Seoul National University Hospital, with accuracy and registration time as the main measures.

A new ClinicalTrials.gov registry observation shows a recruiting study of AR-based neuronavigation at Seoul National University Hospital. The study is currently listed as RECRUITING, and its primary completion date is 2026-12-31, so this is an active study with no posted results yet.

For a general reader, the key point is simple: the trial is trying to see how well augmented reality, or AR, helps guide surgery. In plain terms, AR-based navigation overlays digital guidance onto a live surgical setting, and this study is built to measure how closely that guidance matches real anatomy and how long the setup takes.

"This record describes a study and its registry status; study outcomes require posted results." — ctgov_v2

What the study is measuring

The trial uses a single-arm design and lists AR-based navigation as the intervention. Its main accuracy measure is Target Registration Error, abbreviated TRE, which the record defines as the linear distance in millimeters between the landmark shown by MEDIP PRO AR and the actual position on the patient’s skin or skull surface.

That measurement is taken immediately after AR registration and before surgical draping on the day of surgery. The record says the team will check three fixed landmarks per participant: right Kocher's point, left Kocher's point, and glabella.

Why timing matters in the operating room

The other primary outcome is registration time. The record defines this as the time, in minutes and seconds, from AR software launch to completion of registration, based on retrospective analysis of intraoperative video recording.

That matters because a tool can be accurate and still be awkward to use if setup takes too long. The registry observation says the study will report the timing separately for manual and automatic registration, which suggests the team wants to compare workflow as well as precision.

Part of a broader cancer research moment

This study appears within the active special event Cancer Breakthroughs, alongside other registry observations that also focus on cancer care, cancer surgery, and cancer-related treatment questions. One related item in the same event is a prospective surgical study on the pattern of electrical activity in high grade glioma as a predictor of progression, which points to the same broad interest in what can be learned during surgery.

The common thread is not that these studies answer the same question, but that they all show how cancer research is testing new ways to observe, measure, and guide care. In this case, the AR-based neuronavigation study adds a surgical-navigation angle to that larger picture.